M2 PressWIRE - October 31, 2006 - Adult stem cells are undifferentiated cells found throughout the body that divide to replenish dying cells and regenerate damaged tissues. Research into adult stem cells has been fueled by their abilities to divide or self-renew indefinitely and generate all the cell types of the organ from which they originate - potentially regenerating the entire organ from a few cells.
The market for stem cell products and services is forecast to grow almost three-fold from $24.6 billion US in 2005 to $68.9 billion US in 2010. During the years 1980-2005, over 2,000 US patents claiming stem cell technologies and applications relevant to healthcare were published. The annual rate of publication has accelerated sharply starting in 2002 and shows no signs of slowing down.
The Emerging Stock Report is covering CalbaTech, Inc. (OTC Bulletin Board: CLBE), an emerging life sciences company concentrating on banking adult stem cells for possible future therapeutic uses and providing products and platforms to the biotech and pharmaceutical research markets and to academic institutions. CalbaTech's wholly owned subsidiary LifeStem has developed a unique process to harvest stem cells in micro quantities to be cryopreserved for future transplantation into a client for medical purposes. The collection of stem cells from two different tissue sources increases the potential for treatment of more diseases.
LifeStem, Inc. has won the 2006 Innovation in Science award presented by Orange County Innovation (OCI).
LifeStem recently introduced the LifeStem MicroBank(TM) Service, its service that allows healthy individuals the ability to collect their own adult stem cells from both peripheral blood and adipose tissue. The stem cells are then cryogenically stored for possible future therapeutic use. LifeStem anticipates more than 1,000 clients will take advantage of its service during its first year, with revenues topping $3.9 million The Emerging Stock Report is a sector specific newsletter that strives to bring information to the attention of the investment community ahead of the market, providing concise analysis and the resources required in determining when a stock appears poised for growth.
Get a Complimentary Subscription at www.*********************** Subscribers have access to investment research reports, tools for tracking and analyzing, current news, detailed company profiles and ESR "E-Alert" Services. ESR produces comprehensive, timely and dependable research available on the Internet.
Safe Harbor
All material herein was prepared by the Emerging Stock Report (ESR) www.*********************** based upon information believed to be reliable. The information contained herein is not guaranteed by ESR to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. ESR is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. ESR may receive compensation in cash or shares from independent third parties or from the companies mentioned.
ESR's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. ESR will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
((Comments on this story may be sent to info*m2.com))
Topic Closed
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
